HMGB1 and metabolic disease: The reason for this is believed to be consistent with the above inference; that is, the intensified inflammatory response caused by HMGB-1 inhibits the secretion of AChE, which enhances the self-digestion ability of pancreatic enzymes and worsens metabolic disorders in patients, resulting in a significant loss of nutritional proteins.